OOIR: Observatory of International Research

Papers

(The TQCC of Microbes and Infection is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-12-01 to 2023-12-01.)

Article	Citations
Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses	513
Is COVID-19 receiving ADE from other coronaviruses?	317
The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future	242
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China	240
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2	144
Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster	137
Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes	131
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses	122
Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses	101
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients	93
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement	91
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study	89
Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency	81
Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases	77
Could nasal nitric oxide help to mitigate the severity of COVID-19?	66
Arbidol/IFN-α2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study	66
Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season	61
Molecular basis of COVID-19 relationships in different species: a one health perspective	53
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis	51
Bacterial and fungal co-infections among COVID-19 patients in intensive care unit	47
Anti-science extremism in America: escalating and globalizing	40
Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine	39
Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19	39
Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China	38
COVID19 meets the antivaccine movement	37

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development	36
Current development of COVID-19 diagnostics, vaccines and therapeutics	35
Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants	34
Pneumonia caused by Mycobacterium tuberculosis	28
Coxiella burnetii: international pathogen of mystery	26
Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types	26
NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity	25
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system	19
Impact of non-pharmaceutical interventions during the COVID-19 pandemic on common childhood respiratory viruses – An epidemiological study based on hospital data	19
Prolonged viral shedding and antibody persistence in patients with COVID-19	19
Does the hygiene hypothesis apply to COVID-19 susceptibility?	19
Metformin promotes Mycobacterium tuberculosis killing and increases the production of human β-defensins in lung epithelial cells and macrophages	18
Levels of miR-125a-5p are altered in Mycobacterium avium-infected macrophages and associate with the triggering of an autophagic response	17
Chloroquine paradox may cause more damage than help fight COVID-19	17
Cause or effect? The spatial organization of pathogens and the gut microbiota in disease	16
Digging the rabbit hole, COVID-19 edition: anti-vaccine themes and the discourse around COVID-19	16
It is too soon to attribute ADE to COVID-19	15
The Pseudomonas aeruginosa HSP90-like protein HtpG regulates IL-8 expression through NF-κB/p38 MAPK and CYLD signaling triggered by TLR4 and CD91	15
Management of COVID-19: current status and future prospects	15
Complement mediated Klebsiella pneumoniae capsule changes	15
Detection of Mayaro virus in Aedes aegypti mosquitoes circulating in Goiânia-Goiás-Brazil	15
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)	14
Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19	14
Coronavirus vaccine-associated lung immunopathology-what is the significance?	14
Autophagic induction modulates splenic plasmacytoid dendritic cell mediated immune response in cerebral malarial infection model	13
The synergistic triad between microcin, colibactin, and salmochelin gene clusters in uropathogenic Escherichia coli	12
Transcriptional ups and downs: patterns of gene expression in the life cycle of Toxoplasma gondii	12
Pathogenesis and immune response in Brucella infection acquired by the respiratory route	12
Calpain regulates CVB3 induced viral myocarditis by promoting autophagic flux upon infection	12
The metaeffector MesI regulates the activity of the Legionella effector SidI through direct protein–protein interactions	12
Combination of colistin and tobramycin inhibits persistence of Acinetobacter baumannii by membrane hyperpolarization and down-regulation of efflux pumps	12
Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis	12
COVID-19 vaccine decisions: considering the choices and opportunities	11
Retrograde axonal transport property of adeno-associated virus and its possible application in future	11
Trypanosoma cruzi extracellular amastigotes selectively trigger the PI3K/Akt and Erk pathways during HeLa cell invasion	11
Increased susceptibility to Mycobacterium tuberculosis infection in a diet-induced murine model of type 2 diabetes	11
Increased IL-8 levels in HIV-infected individuals who initiated ART with CD4+ T cell counts <350 cells/mm3 – A potential hallmark of chronic inflammation	11
Comparative proteomics in the three major human pathogenic species of the genus Sporothrix	11
Therapeutic approaches for combating Pseudomonas aeruginosa infections	11
The fate of house cats during the COVID-19 pandemic	10
Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis	10
The intestinal microbiota: from health to disease, and back	10
Enhanced expression of NLRP3 inflammasome components by monocytes of patients with pulmonary paracoccidioidomycosis is associated with smoking and intracellular hypoxemia	10
Unraveling Ascaris suum experimental infection in humans	10
Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis	10
The Forrest Gump approach to preventing severe COVID-19 – reverse the predisposing pro-inflammatory state with exercise	10
Dihydromyricetin is a new inhibitor of influenza polymerase PB2 subunit and influenza-induced inflammation	9
COVID-19: comparative clinical features and outcome in 114 patients with or without pneumonia (Nord Franche-Comte Hospital, France)	9
Anti-malarial humoral immunity: the long and short of it	9
Direct correlation between Th1 and Th17 responses in immunity to Brucella infection	9

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector	9
Recurrence of COVID-19 after recovery ? A case series in health care workers, France	9
Chlamydia psittaci in fulmars on the Faroe Islands: a causative link to South American psittacines eight decades after a severe epidemic	9
Characterization of reduced susceptibility to chlorhexidine among Gram-negative bacteria	9
Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection	8
Could targeting immunometabolism be a way to control the burden of COVID-19 infection?	8
The COVID-19 epidemic and other notifiable infectious diseases in China	8
BFRF1 protein is involved in EBV-mediated autophagy manipulation	8
Machine learning-based investigation of the relationship between gut microbiome and obesity status	8
The microbiota protects against Pseudomonas aeruginosa pneumonia via γδ T cell-neutrophil axis in mice	8
The influence of pH on Staphylococcus saprophyticus iron metabolism and the production of siderophores	8
Anti-tuberculosis (TB) chemotherapy dynamically rescues Th1 and CD8+ T effector levels in Han Chinese pulmonary TB patients	8
The immunopathogenesis of tuberculous pericarditis	8
Substantial induction of non-apoptotic CD4 T-cell death during the early phase of HIV-1 infection in a humanized mouse model	8
COVID-19: disease, or no disease? - that is the question. It’s the dose stupid!	7
Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals	7
Ripk3 licenced protection against microbial infection in the absence of Caspase1-11 inflammasome	7
Prophylactic and therapeutic vaccines against sporotrichosis. Feasibility and prospects	7
COVID-19 and Fungal infections: a double debacle	7
Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection	7
Staphylococcus epidermidis small colony variants, clinically significant quiescent threats for patients with prosthetic joint infection	7
Characterization of Brucella abortus S19 as a challenge strain for use in a mouse model of brucellosis	7
Galactosaminogalactan secreted from Aspergillus fumigatus and Aspergillus flavus induces platelet activation	7
Patient-derived Enterococcus mundtii and its capsular polysaccharides cause depression through the downregulation of NF-κB-involved serotonin and BDNF expression	7
Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza	7
Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-2	7
Airborne infection with Covid-19? A historical look at a current controversy	7
Human mesenchymal stem cell based intracellular dormancy model of Mycobacterium tuberculosis	7
Modulation of human endogenous retroviruses –H, -W and -K transcription by microbes	7
Host poly(ADP-ribose) polymerases (PARPs) in acute and chronic bacterial infections	7